
DMRA vs ZYME
$DMRA vs $ZYME head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DMRA vs ZYME: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+7.8%). Split-adjusted daily closes.
- ·Neither kept up with the market over the past year: DMRA -9.9% and ZYME +2.3%, against the S&P 500 at +7.8%.
- ·The last month has flipped the order: DMRA leads over the month (+11.2% against -3.2%) even though ZYME leads over the year.
- ·DMRA sits closer to its support, 8.8% above it at $20.90, while ZYME is 8.8% above its own at $23.88.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
DMRA vs ZYME: the quick read
- ·ZYME is the larger company by market cap ($1.81B vs $1.40B).
- ·DMRA has been more active on our scanner (118 vs 116 alerts in 30 days).
- ·ZYME has the smaller float (43.5M vs 61.7M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 118 and 116 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 30% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching DMRA or ZYME? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DMRA and ZYME on TheDesperateTrader.
- Is DMRA or ZYME the better stock?
- "Better" depends on your goal, and these two are not alike. ZYME is the larger company by market cap ($1.81B vs $1.40B). DMRA has been more active on our scanner (118 vs 116 alerts in 30 days). ZYME has the smaller float (43.5M vs 61.7M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DMRA and ZYME?
- The differences that matter: they are similar in size ($1.40B vs $1.81B); they trade at very different share prices ($22.92 vs $26.20); DMRA sits at 35% of its 52-week range against 45% for ZYME; our scanner flagged DMRA 118 times in the last 30 days against 116 for ZYME. Everything above is measured from the latest completed session and SEC filings.
- Which of DMRA and ZYME is more active right now?
- Right now DMRA is at about 0.8x its normal volume and ZYME is at about 0.4x, so DMRA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is DMRA or ZYME in the stronger trend?
- DMRA is above its 50-day average of $21.84; ZYME is below its 50-day average of $27.20 and above its 200-day average of $25.57. ZYME leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DMRA or ZYME? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DMRA and ZYME comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.